Laparoscopy Devices Market Size and Share
Market Overview
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 8.64 Billion |
| Market Size (2030) | USD 12.49 Billion |
| Growth Rate (2025 - 2030) | 7.65% CAGR |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. |
|
Laparoscopy Devices Market Analysis by Mordor Intelligence
The laparoscopic devices market is valued at USD 8.64 billion in 2025 and is forecast to reach USD 12.49 billion by 2030, advancing at a 7.65% CAGR. Momentum is underpinned by the rising preference for minimally invasive procedures, steady regulatory support for AI-enabled surgical systems, and wider availability of ambulatory surgical centers. Sustained demand also comes from the convergence of 4K and 3D imaging, robotic platforms that improve dexterity, and growth in obesity-related metabolic surgeries. Manufacturers are responding with reusable tool innovations that address sustainability concerns while maintaining sterility standards. Simultaneously, regional supply-chain diversification mitigates logistics risks and tightens delivery timelines for key components.
Key Report Takeaways
- By product, energy devices led with 27.41% revenue share in 2024, while robotic-assisted platforms are projected to post the fastest 8.61% CAGR through 2030.
- By application, general surgery accounted for 29.87% of the laparoscopic devices market share in 2024; gynecological surgery is positioned to grow at an 8.29% CAGR to 2030.
- By age group, adults dominated at 62.46% in 2024, whereas the geriatric cohort is set to expand at an 8.23% CAGR.
- By end user, hospitals held 66.37% of the laparoscopic devices market size in 2024, but ambulatory surgical centers are expected to climb at an 8.39% CAGR.
- By geography, North America captured 40.39% revenue share in 2024; Asia-Pacific is forecast to register the highest 8.56% CAGR through 2030.
Global Laparoscopy Devices Market Trends and Insights
Drivers Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising demand for minimally-invasive procedures | +1.8% | Global; strongest in North America and Europe | Medium term (2-4 years) |
| 4K/3D/AR and AI visualization breakthroughs | +1.5% | North America and European Union lead; APAC catching up | Long term (≥ 4 years) |
| Growing obesity and metabolic disease burden | +1.2% | Global; concentrated in high-income economies | Long term (≥ 4 years) |
| Accelerated ambulatory surgical center build-out | +1.0% | North America and Europe core; APAC expansion | Medium term (2-4 years) |
| Shift toward single-use instruments | +0.8% | Global | Short term (≤ 2 years) |
| AI-enabled intra-operative analytics | +0.7% | North America and Europe early adoption | Long term (≥ 4 years) |
Source: Mordor Intelligence
Rising Demand for Minimally-Invasive Procedures
Elective and acute surgeries increasingly favor laparoscopic techniques because average hospital stays fall by 2–3 days, and postsurgical recovery accelerates. Hospitals benefit from lower readmission rates, while patients report less postoperative pain and faster return to work. Fellowship enrollments in minimally invasive surgery have risen, ensuring a steady pipeline of skilled practitioners. The virtuous cycle of patient preference, payer support, and surgeon competency continues to lift the laparoscopic devices market.
Technological Leaps Including 4K/3D/AR and AI Vision
New imaging stacks quadruple resolution and add depth perception that reduces error rates in intricate dissections. AI-enabled systems such as the da Vinci 5 supply predictive analytics that anticipate instrument trajectory, helping surgeons identify critical structures sooner. Augmented reality overlays align preoperative scans with live anatomy and shorten operative times, improving operating-room turnover.
Growing Prevalence of Obesity & Metabolic Disease
Bariatric volumes keep rising as obesity reaches pandemic levels. Laparoscopic metabolic procedures remain the gold standard for sustained weight loss and diabetes remission, even as GLP-1 agonists gain traction, with combination therapy producing longer-term success. Robotic platforms lower complication rates further, reinforcing uptake at high-volume centers.
Rapid Ambulatory Surgical Centers Build-Out in High-Income Economies
Ambulatory surgical centers (ASCs) deliver procedures at markedly lower cost than hospital outpatient departments and now attract complex laparoscopic workloads. Portable towers and compact insufflators designed for rapid case turnover optimize ASC efficiency. Payment parity policies encourage migration of appropriate procedures to these sites, propelling demand for cost-effective but advanced systems.
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High capital & maintenance outlay | -1.2% | Global; acute in emerging markets | Medium term (2-4 years) |
| Shortage of advanced-skill laparoscopic surgeons | -0.8% | Global; severe in developing regions | Long term (≥ 4 years) |
| Sustainability backlash on disposable plastics | -0.6% | Europe and North America | Medium term (2-4 years) |
| Endoluminal therapies cannibalizing procedure share | -0.4% | North America and Europe | Long term (≥ 4 years) |
Source: Mordor Intelligence
High Capital & Maintenance Outlay
Fully-featured robotic suites can cost USD 2–3 million with ongoing service fees topping USD 200,000 annually, delaying purchases by mid-tier hospitals. Supply chain turbulence has lifted logistics costs, causing providers to scrutinize total cost of ownership. Pay-per-use financing and shared-ownership models have emerged to counterbalance these barriers.
Shortage of Advanced-Skill Laparoscopic Surgeons
Training requirements remain steep and senior mentorship capacity limited, producing regional care gaps. VR simulators now reduce learning curves and AI-guided modules gauge proficiency in real time [1]Miranda X. Morris, “Current and Future Applications of Artificial Intelligence in Surgery,” Frontiers in Surgery, frontiersin.org. Even so, workforce shortfalls may restrain procedure volumes in lower-income regions until upskilling accelerates.
Segment Analysis
By Product: Robotic Systems Drive Innovation
Energy instruments held the largest slice of the laparoscopic devices market at 27.41% in 2024 because almost every procedure requires electrosurgery or tissue sealing. Robotic-assisted systems, while smaller in absolute volume, are forecast to post an 8.61% CAGR through 2030. That expansion will lift the laparoscopic devices market size for robotic suites to USD-denominated double-digit billions by decade-end. Next-generation laparoscopes integrate 4K/3D optics, automated white-balance, and leak-proof trocar seals that maintain stable pneumoperitoneum. Hand instruments adopt haptic feedback motors that lessen surgeon fatigue during lengthy bariatric cases. Disposable trocars continue shifting toward plant-based or recyclable materials to address environmental targets. Manufacturers also bundle service analytics that predict instrument wear, limiting unplanned downtime.
The pivot to single-use instruments spreads quickly across suction-irrigation and stapler lines because hospitals calculate that reprocessing costs can surpass USD 200 per item. Smart energy devices now feature tissue-contact sensors that moderate thermal spread, improving safety in confined spaces. Premium accessory lines thus supply recurring revenue that softens pricing pressure on capital equipment.
Note: Segment shares of all individual segments available upon report purchase
By Application: Gynecological Surgery Accelerates
General surgery contributed the largest 29.87% slice of the laparoscopic devices market in 2024, owing to high volumes of cholecystectomy and anti-reflux procedures. Gynecology, however, shows the highest 8.29% CAGR as robotic hysterectomy adoption widens. That trajectory will lift gynecology’s laparoscopic devices market share notably by 2030.
In colorectal and urological surgery, AI-enabled cameras help clinicians consistently achieve critical-view benchmarks, slashing intraoperative injuries. Bariatric volumes rise steadily with obesity growth, while robotic platforms further shorten hospital stays. Thoracic and pediatric segments remain smaller yet gain momentum from tool miniaturization.
By Age Group: Geriatric Segment Surges
Adults commanded 62.46% of the laparoscopic devices market share in 2024, yet the geriatric cohort is advancing at an 8.23% CAGR that will noticeably lift the laparoscopic devices market size by 2030. Hospitals increasingly clear older patients for minimally invasive procedures as enhanced recovery programs and refined anesthesia protocols lower postoperative risk. Shorter inpatient stays and faster return to baseline function have made laparoscopy the preferred approach for oncologic, hernia, and gallbladder interventions in seniors.
Surgeons report fewer wound complications and lower pulmonary morbidity among geriatric patients when operations are performed laparoscopically rather than through open incisions, reinforcing physician confidence [2]Rebecca Barbaresso, "Should Laparoscopy be Performed in the Morbidly Obese? An Expert Opinion Supporting Conventional Laparoscopy and Intraoperative Considerations for the Patient with Obesity with Benign Gynaecological Conditions," BMJ Journals, gocm.bmj.com. Device makers are responding with age-specific instrumentation that features slimmer shafts, gentler tip profiles, and ergonomic handles to reduce operating-room fatigue during lengthier oncologic cases. At the same time, AI-driven visualization platforms help surgeons navigate fragile anatomy, improving precision and decreasing conversion rates to open surgery. The combination of demographic momentum and demonstrable clinical benefits positions the geriatric segment as a key long-term growth engine within the broader laparoscopic devices market.
Note: Segment shares of all individual segments available upon report purchase
By End User: ASCs Challenge Hospital Dominance
Hospitals retained 66.37% of global revenue in 2024 by handling high-acuity and multi-procedure cases, but ambulatory surgical centers (ASCs) are forecast to expand at an 8.39% CAGR and steadily erode that lead. Payer initiatives that equalize reimbursement across care settings, together with patient demand for same-day discharge, are steering gallbladder, hernia, and bariatric procedures toward outpatient venues. This migration will enlarge the laparoscopic devices market size captured by ASCs through 2030.
ASC operators are investing in compact towers, mobile insufflators, and single-port wristed instruments optimized for rapid case turnover and limited footprint environments. Disposable trocar and clip-applier kits bundled with service contracts simplify inventory management while safeguarding sterility, a critical requirement for high-volume outpatient workflows. Manufacturers that pair equipment leasing with on-site staff training capture loyalty and minimize capital barriers for new centers. As more spine and urology cases transition to outpatient settings, the ASC channel will grow in strategic importance, prompting device suppliers to tailor product roadmaps specifically for this fast-scaling customer segment.
Geography Analysis
North America controlled 40.39% of global revenue in 2024, anchored by dense installed bases and favorable reimbursement. United States facilities logged double-digit growth in robotic general surgery cases after the da Vinci 5 launch. Canadian hospitals replicate performance through provincial funding schemes, while Mexico increases private-sector adoption to serve cross-border medical tourists.
Asia-Pacific is forecast to post the fastest 8.56% CAGR. Chinese hospitals continue large-scale build-outs and accelerate local production of cost-optimized robotic platforms following recent domestic approvals. Japan and South Korea leverage their imaging expertise to export high-resolution camera stacks. India’s tier-one cities witness robust demand, though rural uptake remains slower due to capital limitations. Medical-tourism corridors in Thailand and Malaysia further boost case volumes.
European growth is stable, supported by national health insurance and surgeon training networks. Budget caps, however, can delay broad robotic acquisition outside Northern Europe. Intra-region initiatives promote reusable instrument procurement to align with decarbonization goals. The Middle East and Africa observe rising adoption in Gulf Cooperation Council states investing in flagship medical cities, whereas sub-Saharan Africa relies heavily on donor-funded MIS programs [3]Adebayo Falola, “Orienting Global Surgery Initiatives Toward Advancing Minimally Invasive Surgery in Africa,” BMC Surgery, biomedcentral.com. South America sees moderate gains centered on Brazil’s private insurers and Argentina’s public-sector modernization.
Competitive Landscape
Industry concentration remains fragmented. Intuitive Surgical, Medtronic, Johnson & Johnson MedTech, and Stryker collectively hold a sizeable installed base, but nimble entrants launching single-port robots and wristed handhelds erode incumbent share.
AI software updates delivered under new FDA-predetermined change control pathways allow premium vendors to extend asset life cycles without hardware swaps. Vertical integration trends pair imaging platforms with analytics dashboards, increasing switching costs for hospitals.
Supply-chain resilience strategies push manufacturers to dual-source semiconductors and establish regional assembly hubs. Sustainability adds another dimension of competition; firms that commercialize low-plastic or reusable portfolios may qualify for environment-linked tenders. Global OEMs also sponsor surgeon-training academies that certify proficiency on specific platforms, further embedding their ecosystems.
Laparoscopy Devices Industry Leaders
-
Karl Storz GmbH & Co.KG
-
Olympus Corporation
-
Boston Scientific Corporation
-
Johnson & Johnson (Ethicon)
-
Medtronic plc
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- May 2025: MicroPort received Chinese NMPA approval for the Toumai SP laparoscopic robot in urology, general surgery, and gynecology.
- October 2024: LivsMed launched ArtiSential 5, the first 5 mm wristed articulating laparoscopic instrument series.
- July 2024: The FDA cleared an expanded indication for Asensus Surgical’s Senhance digital laparoscopy system in adult and pediatric urology.
- April 2024: Medtronic unveiled new AI algorithms for postoperative analysis and introduced Touch Surgery Live Stream for real-time OR collaboration.
Global Laparoscopy Devices Market Report Scope
As per the scope of the report, laparoscopy is referred to as a type of surgery in which small incisions are made in the body, such as the abdominal wall through which a laparoscope, as well as other instruments, can be placed to allow structures within the internal body cavity to be seen. Various probes or other instruments can also be pushed through these small incisions in the skin, thus, enabling several activities, including both diagnosis and treatment.
The laparoscopy devices market is segmented by product (energy devices, laparoscopes, insufflation devices, handheld instruments, suction/irrigation devices, and other products), by application (bariatric surgery, gynecological surgery, colorectal surgery, and other applications), by end user (ambulatory centers, hospitals and clinics, and other end users), and by geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Product | Energy Devices | Electrosurgical / Bipolar Generators | |
| Ultrasonic & RF Energy Systems | |||
| Laparoscopes | Video Laparoscopes (HD/4K/3D) | ||
| Fibre-optic Laparoscopes | |||
| Insufflation & Access Devices | CO2 Insufflators | ||
| Trocars & Cannulas | |||
| Handheld Instruments | Graspers & Dissectors | ||
| Scissors & Shears | |||
| Suction / Irrigation Devices | |||
| Robotic-Assisted Laparoscopy Systems | |||
| Accessories & Consumables | |||
| By Application | General Surgery | ||
| Bariatric Surgery | |||
| Gynecological Surgery | |||
| Urological Surgery | |||
| Colorectal Surgery | |||
| Other Applications | |||
| By Age Group | Adults | ||
| Pediatric | |||
| Geriatric | |||
| By End User | Hospitals | ||
| Ambulatory Surgical Centers (ASCs) | |||
| Others | |||
| By Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| South Korea | |||
| Australia | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
| Energy Devices | Electrosurgical / Bipolar Generators |
| Ultrasonic & RF Energy Systems | |
| Laparoscopes | Video Laparoscopes (HD/4K/3D) |
| Fibre-optic Laparoscopes | |
| Insufflation & Access Devices | CO2 Insufflators |
| Trocars & Cannulas | |
| Handheld Instruments | Graspers & Dissectors |
| Scissors & Shears | |
| Suction / Irrigation Devices | |
| Robotic-Assisted Laparoscopy Systems | |
| Accessories & Consumables |
| General Surgery |
| Bariatric Surgery |
| Gynecological Surgery |
| Urological Surgery |
| Colorectal Surgery |
| Other Applications |
| Adults |
| Pediatric |
| Geriatric |
| Hospitals |
| Ambulatory Surgical Centers (ASCs) |
| Others |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| South Korea | |
| Australia | |
| Rest of Asia-Pacific | |
| Middle East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
Key Questions Answered in the Report
What is the current value of the laparoscopic devices market?
The market is worth USD 8.64 billion in 2025 and is projected to reach USD 12.49 billion by 2030.
Which product segment holds the largest share?
Energy devices lead with 27.41% revenue share in 2024.
Which application area is expanding the fastest?
Gynecological surgery is forecast to grow at an 8.29% CAGR through 2030.
Why are ambulatory surgical centers important to future growth?
ASCs deliver procedures at lower cost, attract patient preference, and will expand at an 8.39% CAGR, challenging hospital dominance.
Which region offers the highest growth opportunity?
Asia-Pacific is expected to record an 8.56% CAGR owing to infrastructure investment and rising disposable incomes.
How is sustainability influencing device design?
Hospitals increasingly favor reusable or recyclable instruments, prompting manufacturers to launch low-plastic alternatives that meet infection-control requirements.
Page last updated on: June 12, 2025
